secondary Parkinson disease
secondary Parkinson disease
Explore linked clinical trials. Standard reference: MONDO:00069665 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, secondary Parkinson disease, synucleinopathy | Recruiting | Not applicable | 2026-07-21 | NCT07568067 | |
| Terazosin and Parkinson's Disease Extension Study | Nerve Degeneration, Parasomnias, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, REM Sleep Parasomnias, REM sleep behavior disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, secondary Parkinson disease, sleep-wake disorder, synucleinopathy | Active, not recruiting | Phase 2 | 2026-03-02 | NCT05109364 | |
| Terazosin Effect on Cardiac Changes in Early Parkinson's Disease | Parasomnias, REM Sleep Parasomnias, REM sleep behavior disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, parkinsonian disorder, psychiatric disorder, secondary Parkinson disease, sleep-wake disorder | Active, not recruiting | Phase 2 | 2026-03-02 | NCT04386317 | |
| Cardiac Changes in Early Parkinson's Disease: A Follow up Study | Parasomnias, REM Sleep Parasomnias, REM sleep behavior disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, parkinsonian disorder, psychiatric disorder, secondary Parkinson disease, sleep-wake disorder | Active, not recruiting | Phase 2 | 2026-03-02 | NCT04218968 | |
| Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136) | Nerve Degeneration, Parasomnias, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, REM Sleep Parasomnias, REM sleep behavior disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, secondary Parkinson disease, sleep-wake disorder, synucleinopathy | Active, not recruiting | Phase 2 | 2026-03-02 | NCT03775096 |